Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > AMGN > Summary

Amgen Inc.
(AMGN)

57.21USD   Down 0.25 (0.44%)   
At 2:30AM IST
 Amgen Inc. (NasdaqNM:AMGN) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 57.21USD
Trade Time:2:30AM IST
Change:Down 0.25 (0.44%) 
Prev Close:57.46
Open:58.17
Bid:57.10 x 1000
Ask:57.22 x 200
1y Target Est:69.24
Day's Range:56.70 - 58.40
52wk Range:44.96 - 64.76
Volume:18,732,186
Avg Vol (3m):6,527,030
Market Cap:56.92B
P/E (ttm):12.48
EPS (ttm):4.59
Div & Yield:N/A (N/A%)
Add AMGN to Portfolio   Download Data

HEADLINES

 
•U.S. Stocks Gain on Hopes for Greece Aid - The Wall Street Journal Online  - Wed 8:39AM
•Amgen's denosumab offers hope in rare bone tumours - Reuters  - Wed 5:31AM
•Coca-Cola and industrials help stocks rally - FT.com  - Wed 3:50AM
•Amgen, Apple: Money Flow Leaders (AMGN, AAPL) - The Wall Street Journal Online  - Wed 2:55AM
•Dow Over 10,000; Greek Rescue Plan Pondered - SmartMoney.com  - Wed 1:47AM
•Don't Invest Another Penny - Motley Fool  - Tue 11:11PM
•Bone Up On This Potential Blockbuster - Motley Fool  - Tue 10:28PM
•Amgen sees positive data in bone drug study - AP  - Tue 9:28PM
•Positive Results on Amgen Drug - Zacks.com  - Tue 9:19PM
•Indications: U.S. futures recover after sub-10,000 Dow close - MarketWatch  - Tue 7:29PM
•UPDATE - Amgen: denosumab prostate cancer trial meets goals - Reuters  - Tue 6:09AM
» More Headlines for AMGN...

ANALYST

 
EPS Est (next year) (Dec-09) :5.00
EPS Est (in 2 years) (Dec-10) :5.14
Avg Rec (current)*:1.9
PEG Ratio:1.33
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Amgen Inc., a biotechnology company, engages in the discovery, development, manufacture, and marketing of human therapeutics based on advances in cellular and molecular biology.

» Full Company Profile